
· Executive Brief
Sexual Health Awareness Month 2026
A practical executive framework for access, ownership, handoffs, measurement, and improvement.

Leadership signal
Sexual Health Awareness Month can serve as an executive operating checkpoint.
Awareness can generate questions and requests for help. Executive teams can prepare by clarifying the first point of contact, the qualified team that accepts the request, the handoff standard, and the method used to verify completion without assuming that one route fits every person.
Start by distinguishing what is known from what the organization still needs to learn. A campaign plan, communication volume, or meeting count does not establish that a route is usable. Leaders need direct listening, clear ownership, locally defined measures, and a method for keeping exceptions visible.
Executive opening
Sexual health services succeed or fail at the handoffs
Sexual Health Awareness Month gives leaders a reason to look past campaign reach and ask a harder question. Can a person who seeks confidential testing finish the journey? That journey runs from first contact through specimen collection, result notification, treatment, partner services and, where indicated, prevention such as PrEP. Each step is a handoff, and each handoff can fail quietly. Awareness campaigns can raise demand quickly. If the route behind them is unclear, new demand simply becomes new loss.
Published studies show where those failures occur. At one Southern county health department, only 42% of people started on rapid PrEP continued at three months.[1] In a South African antenatal cohort, 59% of women treated for an infection attended the scheduled test-of-cure visit within the window.[8] At a large urban emergency department, only 4.7% of encounters with a positive pregnancy test included syphilis testing.[5]
The same literature points to designs that work. A free testing program in Zurich drew 3,475 people in its first year.[2] In that program, 39% of visits were by people never previously tested for HIV.[2] A nurse-led sexual health center in San Francisco prescribed antiretroviral therapy to 99% of people who requested it after a lapse in care.[9] Self-collected specimens were widely accepted by PrEP clients in Hanoi.[15] Those designs share a feature: they remove a step, a cost or a delay between the person and the next action.
This brief adds an evidence base to the executive guidance already on this page. It covers burden, the continuum from test to treatment, access routes, equity and trust, the people who run sexual health services, and public communication. The standard throughout is simple. Every person tested should reach a result, a treatment decision and a next step that someone owns.
Current evidence
Burden is steady, and symptoms are a poor gatekeeper
Burden shows up in routine clinic data. In a Boston metropolitan sexual health clinic, at least one STI was recorded at 23% of 7,949 visits between January 2019 and June 2021.[12] Thirteen percent of those visits were by uninsured attendees.[12] At the visit level, attendees were 78% male and 50% White.[12] In a student-run free clinic, positivity across 296 records was 7.1% for chlamydia, 7.1% for syphilis and 4.1% for gonorrhea.[3]
Symptoms do not reliably identify who needs a test. In the free clinic review, roughly half of gonorrhea and chlamydia infections occurred in patients without symptoms.[3] Symptomatic presentation was not significantly associated with positive or negative findings at that clinic.[3] Any route that reserves testing for symptomatic visits will therefore miss a meaningful share of infections. That finding matters for scheduling, staffing and the design of express testing visits that do not depend on a clinical examination.
Most STI care also happens outside specialty clinics. In national commercial claims from 2023 to 2024, offices accounted for 82.1% of 2,964,733 STI-related encounters.[4] Independent laboratories accounted for 12.2%, and emergency, urgent and acute care clinics for 4.8%.[4] The authors caution that claims cannot separate routine screening from diagnostic testing.[4] Even so, the pattern makes sexual health a whole-system service rather than one department’s work. Office-based clinicians, laboratories and urgent care teams all need the same expectations for result follow-up and treatment.
Acute care visits are a frequent missed opportunity. Among 1,770 emergency department visits with positive pregnancy tests at one urban hospital, 13.2% of encounters included HIV testing and 22.9% included gonorrhea or chlamydia testing.[5] More than half (54.5%) of 32 people with gonorrhea or chlamydia were not tested during their emergency visit.[5] Four of the five people with syphilis were also untested at that visit.[5]
Prevention demand is changing as well. In two Dublin sexual health services, 62% of 378 attendees said they were willing to use doxycycline post-exposure prophylaxis, and 9% reported use in the past year.[10] Willingness was higher among attendees with more prior STI diagnoses.[10] It reached 70% in the group of gay, bisexual and other men who have sex with men, transgender women, and non-binary and gender fluid attendees.[10] Services that plan only for testing volume may underestimate the prevention conversations their teams now need to hold.
Figure 1
Sexual health routes lose people after the first contact
Percent of eligible or enrolled people completing a pathway step, as reported in each study. Values are copied from the cited studies [1], [5], [7], [8]; none is estimated.
Data note. These values come from different studies, countries, populations and pathway steps, so this is an indirect comparison; the bars show where routes leak, not how one step compares with another.
Limitation. Each value has its own denominator and setting; the partner treatment value is self-reported and the PrEP value may miss follow-up obtained elsewhere.
Figure data (5 rows)
| Measure | Value | Population, setting and year as reported | Source |
|---|---|---|---|
| Emergency encounters with a positive pregnancy test that included syphilis testing | 4.7% | 1,770 emergency department visits at one large urban U.S. hospital | [5] |
| Home blood spot kits returned among those sent a kit | 39.4% | Māori gay, bisexual and other men who have sex with men, national survey, Aotearoa New Zealand, 2022 | [7] |
| PrEP continuation at three months after rapid initiation | 42% | Durham County Department of Public Health, North Carolina | [1] |
| Partner reported as treated among women attending test of cure | 44% | 48 of 108 pregnant women, East London, South Africa | [8] |
| Treated women attending the test-of-cure visit within the window | 59% | 108 of 183 pregnant women, East London, South Africa | [8] |

Continuum of care
Completion, not testing volume, is the outcome that matters
The continuum often breaks after the test. In the South African antenatal cohort, 193 of 754 women (26%) tested positive for an STI, and 183 (95%) received pathogen-directed treatment.[8] Only 108 of those 183 women (59%) attended the test-of-cure visit within the window.[8] Of the women who returned, 19 (18%) had a positive repeat result.[8] Each return visit is a separate handoff that depends on scheduling, reminders and the patient’s ability to come back.
Partner treatment is the hinge of that pathway. Most returning women (95%) reported telling a partner about the infection, yet only 44% reported that the partner received treatment.[8] Repeat positivity was 4% when partners were treated and 27% when they were not, a risk ratio of 0.15.[8] Disclosure alone did not close the loop for most partners. The difference suggests that partner treatment, rather than notification alone, is the point where the operating route needs support.
A scoping review of U.S. studies reached a similar conclusion. Of 16 included articles on bacterial STI treatment, 13 focused on partner notification and treatment.[11] Intimate partner violence was the social factor most often described as a barrier to partner notification, medication adherence and treatment completion.[11] The review found that systems-level interventions were more effective than individual-level interventions.[11] Five of the included articles described challenges with medication adherence, and no article addressed abstinence during the treatment period.[11]
Prevention linkage shows the same pattern. At the Durham County Department of Public Health, PrEP continuation after rapid initiation was 42% at three months.[1] Almost half of those who missed the three-month appointment later returned to the sexual health clinic, and they were more likely to be female and uninsured.[1] Continuation was positively associated with follow-up at an academic medical center, and the authors suggest that offering full PrEP care at the health department may improve retention.[1]
For executives, these findings define the measure that matters. A completed episode means a result delivered, treatment given, partners reached and prevention continued where indicated. Visit counts and test volumes alone hide the points where people leave the route. Each of those steps can be counted, assigned to an owner and reviewed. A route that tracks only the first visit cannot show whether people were actually treated or protected.
Figure 3
Why the pathway breaks
People
- Time-intensive visits for clients with complex needs
- Clinician concern about antimicrobial resistance with new prevention options
- No dedicated staff to confirm partner treatment
Process
- Testing triggered by symptoms rather than offered routinely
- Test-of-cure and PrEP follow-up visits missed without outreach
- Partner notification relies on slips handed to the patient
Technology
- Home kits sent but not returned
- Electronic partner notices that recipients may not trust
- No shared view of follow-up obtained at other sites
Environment
- Regional residents farther from services
- Emergency visits used instead of prenatal or primary care
- STI stigma and privacy concerns
Policy
- Testing and PrEP costs not covered for some people
- Loss of insurance and relocation interrupt care
- Intimate partner violence limits safe notification
Measurement
- Visit and test counts reported instead of completion
- Results not broken out by age, gender, insurance or geography
- Claims cannot separate screening from diagnostic testing
Unranked qualitative cause-and-effect diagram for the outcome in the box: People tested for STIs do not reliably reach results, treatment, partner treatment and prevention follow-up Causes are assembled from the cited literature [1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [14]; categories are not weighted and their order carries no meaning.
Data note. Qualitative; no frequencies are implied.
Limitation. Causes drawn from published studies may not all apply locally; validate them with frontline teams.
Figure data (6 rows)
| Category | Causes drawn from the cited literature |
|---|---|
| People | Time-intensive visits for clients with complex needs; Clinician concern about antimicrobial resistance with new prevention options; No dedicated staff to confirm partner treatment |
| Process | Testing triggered by symptoms rather than offered routinely; Test-of-cure and PrEP follow-up visits missed without outreach; Partner notification relies on slips handed to the patient |
| Technology | Home kits sent but not returned; Electronic partner notices that recipients may not trust; No shared view of follow-up obtained at other sites |
| Environment | Regional residents farther from services; Emergency visits used instead of prenatal or primary care; STI stigma and privacy concerns |
| Policy | Testing and PrEP costs not covered for some people; Loss of insurance and relocation interrupt care; Intimate partner violence limits safe notification |
| Measurement | Visit and test counts reported instead of completion; Results not broken out by age, gender, insurance or geography; Claims cannot separate screening from diagnostic testing |
Access
Lower the cost and effort of the first test
Cost is a primary barrier, even in wealthy systems. In Switzerland, asymptomatic HIV and STI tests are usually not covered by health insurance, so Zurich launched free voluntary counseling and testing in June 2023.[2] Of the 3,475 people who came in the first year, 83% agreed to share their data.[2] The median age of participants was 24 years, and chlamydia positivity was 4.5%, followed by gonorrhea at 2.5%.[2] The authors describe high demand and many first HIV and STI tests in the first year.[2]
Self-collection can make the clinic visit faster and more acceptable. Among 529 PrEP clients in Hanoi, specimens from all three sites were provided by 97.9%, and 99.4% said they would self-collect again.[15] In conjoint analysis, cost (free versus US $17) had the highest impact on testing preference.[15] The study was set in a clinic-based PrEP program, so the finding speaks directly to services that already see clients regularly. Removing charges and steps appears to matter more than any single technology.
Home collection extends reach but loses people at the return step. Among Māori gay, bisexual and other men who have sex with men in Aotearoa New Zealand, 66.1% of those who reached the kit offer showed interest.[7] Of these, 215 people requested and were sent a dried blood spot kit.[7] Eighty-five specimens came back, 39.4% of those sent a kit.[7] Men who had never tested for HIV were less likely to return a kit (odds ratio 0.37).[7]
Embedded testing inside existing care can find infections that symptom-led visits miss. In three Ryan White HIV/AIDS Program-funded clinics in Florida, self-collected extragenital testing found chlamydia in 11.9% of rectal samples and gonorrhea in 6.5% of pharyngeal samples.[13] The proportion of recommended tests completed was high, although only a subset of at-risk patients completed rescreening.[13] Emergency visits in early pregnancy offer a similar entry point for screening and linkage to prenatal care.[5]
Access is therefore a portfolio rather than a single door. Walk-in visits, express self-collection, home kits and testing embedded in emergency, prenatal and primary care each reach different people. Each route also needs its own completion signal, because a kit mailed or a visit booked is not a result delivered. Leaders can ask how many people enter by each route, how many receive a result, and how many with a positive result are treated.
Executive guidance · System route
Build one visible operating route for Sexual Health Awareness Month.
Use this route as a discussion framework. Replace each stage with the organization’s approved process, qualified roles, current service capacity, and applicable requirements. Do not infer a clinical protocol from the observance title.
The route at a glance
- Listen
- Clarify entry
- Coordinate the partner route
- Protect transitions
- Verify and learn
Reliability rule: Every stage needs a named owner, an observable status, an approved escalation path, and a defined signal that shows whether responsibility moved or remained unresolved.
Listen
Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions.
Clarify entry
Publish a plain-language first step and identify who receives requests through each approved channel.
Coordinate the partner route
Align internal teams and external partners around one current message, real entry point, receiving owner, escalation path, and follow-through signal.
Protect transitions
Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations.
Verify and learn
Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals.
Figure 2
The system route as one flow
The five stages of the system route described in this brief, drawn as one flow with a learning loop back to the start. The stages are the page’s original executive guidance, not a clinical protocol.
Data note. Shows sequence and handoffs only; it carries no counts or rates.
Limitation. Local processes may add, merge or reorder stages under organizational policy.
Figure data (5 rows)
| Stage | What the stage requires |
|---|---|
| Listen | Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions. |
| Clarify entry | Publish a plain-language first step and identify who receives requests through each approved channel. |
| Coordinate the partner route | Align internal teams and external partners around one current message, real entry point, receiving owner, escalation path, and follow-through signal. |
| Protect transitions | Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations. |
| Verify and learn | Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals. |
Equity and trust
Testing gaps follow age, geography, coverage and identity
Testing gaps are rarely random. In a survey of 2,327 people in Victoria, Australia, 41.0% reported no HIV or STI test in the past 12 months.[6] Regional residents were more likely not to test (54.0%) than residents of greater Melbourne (40.0%).[6] No testing was lowest among gay and bisexual cis-men (10.5%) and highest among heterosexual cis-men (57.1%).[6] In total, 17.3% of participants reported an STI diagnosis in the past 12 months.[6]
Age shapes access and prevention. In the same survey, no testing declined from 72.7% among people aged 16 to 19 years to 52.4% at 20 to 24 years.[6] In the Boston clinic, patients aged 15 to 22 years were uninsured at 15% of visits.[12] Young people there were more likely to be unaware of PrEP, and younger females with indications were less likely to be prescribed it.[12] PrEP indication in that analysis was defined using national prevention guidelines.[12]
Coverage gaps follow people through the pathway. In Durham, people who missed a PrEP follow-up visit but later returned to the sexual health clinic were more likely to lack health insurance.[1] The free clinic authors argue that expanding access to asymptomatic testing is essential to reduce missed diagnoses and improve equity.[3] The scoping review also identified language barriers, sexual and gender minority identity, and income as relevant to treatment.[11]
A welcoming environment is part of the access design. In the Florida clinics, youth, lesbian, gay and bisexual, and Hispanic patients were significantly more likely to notice and like LGBTQ+ welcoming measures.[13] Acceptability of computer-assisted sexual history taking, self-collected testing and the welcoming environment was high overall.[13] Privacy concerns and STI stigma also shaped how people in Boston viewed electronic partner notification.[14] Those results suggest that the physical and social signals of a clinic shape who feels able to use it.
Equity review should therefore look at completion, not just attendance. Leaders can ask for every step of the route, from first test to partner treatment and prevention follow-up, to be broken out by age, gender, insurance, geography and population group. Small numbers need careful, protected handling, but they still deserve review. Where gaps appear, the response should be a change to the route, such as a new entry point, extended hours or outreach, rather than a new message alone.

Human infrastructure
Nurses, navigators and partner services carry the pathway
The people who run sexual health services absorb needs that extend well beyond a test. At a nurse-led San Francisco sexual health center, 260 people with known HIV presented for rapid antiretroviral therapy restart between October 2016 and March 2020.[9] Of those presenting, 73% were on therapy, 23% had stopped therapy, and 4% had never started it.[9] Their needs included prescriptions (92%), laboratory results (67%), health navigation (65%) and insurance support (61%).[9] Providers noted that these visits are time-intensive because clients arrive with complex histories and multiple needs.[9]
That model produced results through staff time and coordination. Of 239 people requesting therapy, 99% received prescriptions.[9] Viral suppression was maintained by 76% of those already on therapy and achieved by 66% of those who had been off therapy.[9] Common reasons for presenting were loss of insurance (58%) and relocation (37%), which are administrative problems as much as clinical ones.[9]
Clinician readiness shapes how new prevention options reach patients. Among 52 healthcare workers in two Dublin services, 81% were aware of doxycycline post-exposure prophylaxis studies and 62% believed it could reduce STIs.[10] Among attendees, knowledge of doxycycline prophylaxis was highest in the group most at risk, at 39.3%.[10] Yet 89% had concerns, mainly about antimicrobial resistance.[10] The authors call for national guidelines, ongoing surveillance and research to support equitable and safe prescribing.[10]
Integrated services depend on staff who can run several routes at once. The Florida clinics paired self-interview sexual history software with self-collected extragenital testing and LGBTQ+ welcoming measures across three sites.[13] The Durham experience suggests that rapid PrEP starts need follow-up capacity close to where people first enter care.[1] Partner treatment results from South Africa point to the same gap, since notification slips alone left most partners untreated.[8] Each additional route adds training, supervision and handoff work for the same team.
For leaders, the workforce question is concrete. Who calls with results, who supports partner treatment, who solves insurance problems, and who follows people who miss a visit? Each of those roles needs protected time, clear scope and a link to the clinical team. Without them, test volume can rise while completion falls, and the gap stays invisible to leadership.
Executive guidance · Operating dashboard
Use a small dashboard to expose friction and ownership.
Do not publish a number until the organization defines its numerator, denominator where relevant, owner, source system, exclusions, review cadence, and limits. The candidates below are management prompts, not benchmarks or reported results.
Four operating signals
Each signal pairs an executive question with one candidate local measure, set out below.
Executive guidance · Signal
Entry-point clarity
Can people and staff identify the approved first step without searching across conflicting instructions?
- Candidate local measure
- Locally defined contact, routing, and repeat-contact signals by channel and service.
Executive guidance · Signal
Ownership reliability
Does a specific team accept each request and make its status visible?
- Candidate local measure
- Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
Executive guidance · Signal
Partner-route reliability
Do participating teams share one current route and understand who owns each dependency?
- Candidate local measure
- Locally defined conflicting instructions, unaccepted handoffs, unresolved dependencies, repeat contacts, and partner feedback.
Executive guidance · Signal
Improvement closure
Does the organization correct recurring friction and report what changed?
- Candidate local measure
- Selected barriers, assigned actions, completion status, and post-change review.
Figure 4
The operating system behind the dashboard
The four operating signals from this brief’s dashboard, each tied to the candidate owner named in the executive scorecard, around one accountable route. Drawn from the page’s original executive guidance.
Data note. Structural diagram; no measured values.
Limitation. Owners are candidates to be confirmed locally.
Figure data (4 rows)
| Operating signal | Candidate owner |
|---|---|
| Entry-point clarity | Executive sponsor and operational lead |
| Ownership reliability | Operational owner and participating teams |
| Partner-route reliability | Sending and receiving owners |
| Improvement closure | Improvement owner and executive sponsor |
Executive guidance · Handoff workflow
Close the loop across teams, settings, and partners.
A handoff is reliable only when the sending party knows who is expected to receive the work, the receiving party acknowledges responsibility, and any unresolved exception remains visible. Local policy and qualified judgment control the actual process.
How responsibility moves
Lane A
From message to accepted ownership
- Confirm the approved message and intended audience.
- Publish the actual entry point and receiving role.
- Acknowledge receipt using the locally approved method.
- Escalate when ownership or response remains unclear.
Lane B
From accepted ownership to verified follow-through
- Record the next accountable owner and visible status.
- Name the sending and receiving owners, shared information, current status, and unresolved dependency.
- Keep unresolved work visible across boundaries.
- Confirm closure or document the continuing exception.
Executive guidance · Executive scorecard
Give leaders one view of route reliability and improvement.
The scorecard keeps review focused on decisions. Leaders should set definitions locally, examine variation without overclaiming cause, and pair quantitative signals with the experience of people who use and operate the route.
Who reviews what
- Executive sponsor and operational lead
- Operational owner and participating teams
- Sending and receiving owners
- Improvement owner and executive sponsor
Candidate owners named in the scorecard, confirmed locally.
| Operating signal | Executive question | Candidate owner | Suggested review point |
|---|---|---|---|
| Entry-point clarity | Can people and staff identify the approved first step without searching across conflicting instructions? | Executive sponsor and operational lead | At campaign launch and close |
| Ownership reliability | Does a specific team accept each request and make its status visible? | Operational owner and participating teams | At a locally defined cadence |
| Partner-route reliability | Do participating teams share one current route and understand who owns each dependency? | Sending and receiving owners | At a locally defined cadence |
| Improvement closure | Does the organization correct recurring friction and report what changed? | Improvement owner and executive sponsor | Until action is verified |
Figure 5
Control points for a reliable sexual health route
| Control point | Risk if missing | Owner | Evidence of control |
|---|---|---|---|
| Routine testing offer at emergency, prenatal and primary care entry points | Infections in people without symptoms or prenatal care go undetected | Chief medical officer with emergency and women’s health leaders | Share of eligible encounters with STI testing offered and completed |
| Low-cost, self-collected and home testing routes | Cost and effort deter first-time testers | Ambulatory operations lead and sexual health clinic director | First-time testers by route and kit return rate |
| Result notification and treatment tracking | Positive results go untreated or unconfirmed | Sexual health clinic director | Share of positive results with documented treatment within a locally set interval |
| Partner treatment support, not only notification | Untreated partners and repeat infection | Partner services lead with public health partners | Share of index patients with a partner reported as treated |
| PrEP follow-up outreach and continuation tracking | People stop PrEP after the first months without anyone noticing | HIV prevention program manager | PrEP continuation at three months, including care at partner sites |
| Navigation and insurance support staffing | Administrative barriers interrupt treatment | Chief nursing officer and revenue cycle leader | Navigation caseload and time to resolve coverage problems |
| Stratified completion reporting to leadership | Gaps by age, gender, insurance and geography stay hidden | Chief quality officer and board quality committee | Quarterly completion report with protected small-number review |
Control points derived from the cited evidence [1], [2], [3], [5], [6], [7], [8], [9], [12], [15] and this brief’s executive guidance.
Data note. Each row is a control to verify, not a measured result.
Limitation. Owners and evidence of control must follow local policy and applicable requirements.
Public communication
Trust, privacy and the message that brings people back
Communication in sexual health is mostly about trust and privacy. In interviews with 60 men who have sex with men and transgender women in greater Boston, participants reacted positively to electronic partner notification.[14] Participants had a median age of 27.5 years, and 32% were White, 27% Black and 22% Hispanic.[14] Trust in the notification itself was an important factor in whether people would seek care.[14] Familiarity with contact tracing from the COVID-19 pandemic was a contextual factor that shaped reactions.[14]
The same interviews identified practical barriers. These included anonymous sexual encounters, comfort with clinicians, patterns of using sexual health services, privacy concerns and the nature of relationships between partners.[14] Facilitators included notifiers’ motivation, their knowledge of digital tools and the perceived value of partner notification.[14] A message that reads as an official, confidential service is more likely to prompt a partner to seek testing than one that looks like spam or exposure.
Patient experience data support simple, respectful routes. Mean satisfaction with self-collection in Hanoi was 4.3, and 99.4% would self-collect again.[15] High satisfaction alone does not guarantee completion, so patient experience measures should sit beside return and treatment rates. In Zurich, counseling improved participants’ sexual health knowledge and facilitated many first tests.[2] Home blood spot testing was acceptable to roughly one in five Māori participants who reached the offer, which shows both its reach and its limits.[7]
Messages must also match what happens next. In the South African cohort, nearly all returning women disclosed their infection, yet fewer than half reported partner treatment.[8] Public campaigns that encourage testing should therefore name a real, confidential route to results, treatment and partner services. People with language, income or safety barriers need that route explained in terms that fit their circumstances.[11]
During Sexual Health Awareness Month, the most credible message is a working service. Leaders can describe how to get tested, how results arrive, how partners can be reached confidentially and how prevention continues. Reporting completion openly, without overstating results, builds the trust that brings people back. Staff and community messages should point to the same entry points, and those entry points should be ready for the demand the month creates.

Executive guidance · 90-day plan
Turn the observance into one sustained operating change.
The time boxes below are a management framework, not a clinical timeline. Adjust them to risk, scope, governance, resources, stakeholder participation, and applicable review requirements.
Ninety days, three moves
- Days 1–30See the current route
- Days 31–60Build the reliable path
- Days 61–90Make the change visible
Days 1–30 · Listen and map
See the current route
- Name an executive sponsor and an operational owner.
- Listen to people using the route and representative frontline teams.
- Map how Sexual Health Awareness Month communications connect to real entry points, owners, transitions, and escalation.
- Select one recurring barrier that the organization can responsibly address.
Days 31–60 · Design and test
Build the reliable path
- Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.
- Validate the design with every sending and receiving team involved.
- Test one internal or partner handoff and correct a verified communication, dependency, or ownership gap.
- Test the route in more than one representative setting or operating period where practical.
Days 61–90 · Implement and verify
Make the change visible
- Launch the redesigned route with a small set of locally defined measures.
- Review unresolved work and recurring friction using a learning approach.
- Correct implementation barriers and record who owns each remaining dependency.
- Report what changed, what evidence was reviewed, and what still requires live oversight.
Figure 6
The 90-day plan on one timeline
The 90-day plan from this brief drawn as a timeline: each action sits in the 30-day window the plan assigns it. The full wording of each action is in the figure data and in the plan above.
Data note. Time boxes are a management framework, not a clinical timeline.
Limitation. Durations are uniform 30-day windows; real tasks may span windows.
Figure data (12 rows)
| Window | Action |
|---|---|
| Days 1–30 · Listen and map | Name an executive sponsor and an operational owner. |
| Days 1–30 · Listen and map | Listen to people using the route and representative frontline teams. |
| Days 1–30 · Listen and map | Map how Sexual Health Awareness Month communications connect to real entry points, owners, transitions, and escalation. |
| Days 1–30 · Listen and map | Select one recurring barrier that the organization can responsibly address. |
| Days 31–60 · Design and test | Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal. |
| Days 31–60 · Design and test | Validate the design with every sending and receiving team involved. |
| Days 31–60 · Design and test | Test one internal or partner handoff and correct a verified communication, dependency, or ownership gap. |
| Days 31–60 · Design and test | Test the route in more than one representative setting or operating period where practical. |
| Days 61–90 · Implement and verify | Launch the redesigned route with a small set of locally defined measures. |
| Days 61–90 · Implement and verify | Review unresolved work and recurring friction using a learning approach. |
| Days 61–90 · Implement and verify | Correct implementation barriers and record who owns each remaining dependency. |
| Days 61–90 · Implement and verify | Report what changed, what evidence was reviewed, and what still requires live oversight. |
Executive guidance · Leadership close
Make Sexual Health Awareness Month a starting point, not an endpoint.
Recognition matters. It becomes durable when leaders also listen, clarify the route, support the people operating it, close an identified gap, and report the result without claiming more than the evidence supports.
Leadership commitment
Make ownership visible, test the route, and report what improved.
Executive action kit · Month observance
Turn Sexual Health Awareness Month into accountable action.
A practical executive framework for access, ownership, handoffs, measurement, and improvement.
Leadership focus
Use this observance to examine trustworthy information, prevention access, and community connection. Select one verified barrier, assign an accountable owner, and carry the improvement beyond the campaign window.
Workforce lens
Ask whether staffing, role clarity, training, tools, workload, and escalation support the people operating the information, access, coordination, and follow-through pathway.
Patient and community lens
Make the approved first step clear. Test whether a person can move from information to an acknowledged next action without navigating conflicting instructions.
Equity and access lens
Review language, disability, transportation, digital access, geography, trust, and other barriers using protected feedback and locally appropriate data.
Five-minute briefing
Inspect the operating sequence
Listen with people using the pathway, frontline teams, operational leaders, and community partners. Find one a message, request, referral, or handoff that does not reach an accountable owner, then test the locally approved route from entry through acknowledged follow-through.
- Listen
- Clarify entry
- Coordinate the partner route
- Protect transitions
- Verify and learn
Leadership actions for this week
- Name an executive sponsor and frontline operating owner.
- Ask people using and operating the pathway where ownership becomes unclear.
- Test one representative route from first question to acknowledged next step.
- Select one barrier that can be corrected without overstating the evidence.
- Set a review date and define how completion will be verified.
Candidate measures
Define every numerator, denominator where relevant, owner, data source, exclusions, cadence, and limitation locally. These are management prompts, not external benchmarks.
- Locally defined contact, routing, and repeat-contact signals by channel and service.
- Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
- Locally defined conflicting instructions, unaccepted handoffs, unresolved dependencies, repeat contacts, and partner feedback.
Department readiness checklist
- The public and staff entry points match the actual approved process.
- A specific role accepts each request, referral, or escalation.
- Handoffs include acknowledgment and a visible unresolved state.
- Language, disability, digital, transportation, and trust barriers receive explicit review.
- Communications do not introduce unsupported themes, statistics, or clinical advice.
- A named leader will review what changed after the observance.
Intended audiences
- Executive and Operational Leaders
- Public Health and Community Partners
Staff communication template
During Sexual Health Awareness Month, our organization will connect awareness with a practical review of the information, access, coordination, and follow-through pathway. Use approved information, identify the correct entry point, confirm ownership when work moves, protect privacy, and escalate unresolved barriers through local channels.
Community communication template
Sexual Health Awareness Month is an opportunity to share trustworthy information and make the next step easier to find. Use our approved channels for information and support. If a request changes hands, our goal is to keep ownership and follow-through visible.
Measurement worksheet
- Signal
- What observable condition will show whether the route works?
- Definition
- What is included, excluded, and counted?
- Owner
- Who reviews the signal and acts on exceptions?
- Cadence
- When will leaders review it?
- Equity check
- Which differences require protected, locally appropriate review?
- Closure
- What evidence will confirm the improvement was completed?
- Editorial review
- Completed
- Source records
- 2 listed under Authoritative resources
- Review standard
- Sourced facts remain separated from original executive guidance
- Clinical boundary
- No new statistical or clinical claim was added by this action kit
Sources and content boundary
Authoritative resources
Use note: All operating models, measures, scorecard questions, and action steps are original executive guidance. This article supports leadership planning and education. It does not replace clinical judgment, emergency procedures, legal advice, professional standards, organizational policy, or applicable federal, state, and local requirements.
Peer-reviewed references
References
Fifteen peer-reviewed sources, newest first. Each was individually verified through authenticated academic research databases. Bracketed numbers in the text link here; the original executive guidance on this page carries no citations because it is guidance, not a sourced claim. Sources last checked in those databases on .
- 1.Saxena S, Carrico S, Eagle C, Mazurak K, McKnight-Brown C, Davis A, et al. HIV Pre-exposure Prophylaxis at a Local Public Health Department in the Southern United States: Reducing Barriers, Increasing Access, and Lessons Learned. AIDS and Behavior. 2026;30(7):2234-2241. https://doi.org/10.1007/s10461-026-05048-y
- 2.Arns-Glaser L, Farnham A, Hochstrasser K, Fehr JS, Hampel B. Lowering the barriers to sexual health services: Impacts of free counselling and testing for sexually transmitted infections in Switzerland – an observational study. PLOS ONE. 2026;21(4):e0327114. https://doi.org/10.1371/journal.pone.0327114
- 3.Lee GA, Wang Y, Gluzman I, Meyer G, Dunlop H, Trezza F, et al. No symptoms, no problem? an analysis of asymptomatic and symptomatic sexually transmitted infections and the impact on clinical outcomes in a student-run free clinic. Infection. 2026;54(3):1419-1426. https://doi.org/10.1007/s15010-026-02774-2
- 4.Patel CG, Emerson B, Tao G. Patterns of Sexually Transmitted Infection-Related Testing and Diagnosis by Places of Service, MarketScan Commercial Claims Data, 2023-2024. Sexually Transmitted Diseases. 2026. https://doi.org/10.1097/olq.0000000000002419
- 5.Pierce NV, Almirol E, Stanford KA. The emergency department visit as an opportunity for sexually transmitted infection screening and linkage to care in early pregnancy. The American Journal of Emergency Medicine. 2026. https://doi.org/10.1016/j.ajem.2026.07.043
- 6.Wijekoon D, Griffiths HA, Tomnay J, Latt PM, Soe NN, Phillips TR, et al. Disparities in HIV/STI testing and diagnosis by population groups, geography, and age in Victoria, Australia. Sexual Health. 2026;23(4):SH25258. https://doi.org/10.1071/sh25258
- 7.Padarath S, Haunui K, Ludlam A, Paynter J, Sriamporn KT, McAllister SM, et al. Uptake of at-home self-collected dried blood spots for HIV, hepatitis C and syphilis screening among Māori gay, bisexual and other men who have sex with men in Aotearoa New Zealand: an observational epidemiological study. Sexual Health. 2026;23(4):SH25177. https://doi.org/10.1071/sh25177
- 8.Mdingi MM, Gigi RMS, Babalola CM, Taylor C, Muzny CA, Medina Marino A, et al. Association between partner treatment and repeat sexually transmitted infections positivity in pregnant women in East London, South Africa. Sexually Transmitted Infections. 2026:sextrans-2025-056758. https://doi.org/10.1136/sextrans-2025-056758
- 9.Le Tourneau N, Broussard J, Pearson C, Crouch PC, Diaz Tsuzuki M, Moore K, et al. Rapid Antiretroviral Therapy Restart and HIV Care Relinkage Support at a Sexual Health Clinic in San Francisco. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2026;101(8):844-852. https://doi.org/10.1097/qai.0000000000003884
- 10.Keane A, Lyons F, Smith CJ, Caixeta D, Molina JM, Villa G. Knowledge, attitudes and behaviours in relation to doxycycline post-exposure prophylaxis use among attendees and healthcare workers at two sexual health services in Ireland. Sexually Transmitted Infections. 2026;102(5):318-321. https://doi.org/10.1136/sextrans-2025-056565
- 11.Mueller S, Sutherland JL, Sutherland MA. Scoping Review of Factors Associated With Treatment of Bacterial Sexually Transmitted Infections. Nursing for Women’s Health. 2026;30(1):51-60. https://doi.org/10.1016/j.nwh.2025.08.004
- 12.Neilan AM, Qian Y, Chamberlin G, Hadland SE, Narasimhadevara M, Madhavan V, et al. Differences in Sexual Health Clinic Services by Age and Gender in Metropolitan Boston. Sexually Transmitted Diseases. 2025;53(3):147-154. https://doi.org/10.1097/olq.0000000000002275
- 13.Manavalan P, Gadkowski LB, Sachdeva A, Guha S, Porvasnik S, Nelson JA, et al. Acceptability of Multilevel Sexual Health Interventions and Sexually Transmitted Infection Screening and Testing Among Persons With HIV Across Three Clinical Sites in Florida. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2025;98(3):282-290. https://doi.org/10.1097/qai.0000000000003569
- 14.Eliazer C, Jarolimova J, Zionts D, Garcia M, Magallan V, Thiim A, et al. Implementation Considerations for Electronic Partner Notification for Sexually Transmitted Infections: A Qualitative Analysis Using the Consolidated Framework for Implementation Research. Sexually Transmitted Diseases. 2025;53(1):28-35. https://doi.org/10.1097/olq.0000000000002236
- 15.Bui HTM, Adamson PC, Nguyen TC, Dau NS, Nguyen KD, Pham LQ, et al. Preferences and Acceptability of Testing for Sexually Transmitted Infections in an HIV Pre-Exposure Prophylaxis Clinic in Hanoi, Vietnam. Sexually Transmitted Diseases. 2024;52(4):242-247. https://doi.org/10.1097/olq.0000000000002109
Claim-to-source matrix
What each source supports
Every sourced claim in the new sections maps to the references that support it, the section where it is used, and the limitation a reader should keep in mind. Original executive guidance carries no sources because it is guidance, not a finding.
| Claim group | Sources | Years | Used in | Limitation |
|---|---|---|---|---|
| Clinic burden and asymptomatic infection | [3] [12] | 2026, 2025 | Current evidence | Single-clinic retrospective records from Boston and a student-run free clinic; positivity reflects who chose to test. |
| Where STI testing occurs | [4] | 2026 | Current evidence | Commercially insured people only; claims cannot distinguish screening from diagnostic testing. |
| Missed testing in emergency visits during early pregnancy | [5] | 2026 | Current evidence | One urban hospital; limited to people who later delivered or had ectopic pregnancies there. |
| Partner treatment and repeat infection | [8] [11] | 2026 | Continuum of care | Partner treatment self-reported in one South African trial arm; scoping review of 16 heterogeneous U.S. studies. |
| PrEP continuation after rapid initiation | [1] [9] | 2026 | Continuum of care | Retrospective single-site evaluations in Durham and San Francisco; follow-up elsewhere may be missed. |
| Free, self-collected and home testing access | [2] [7] [13] [15] | 2026, 2025, 2024 | Access | Observational programs in Switzerland, New Zealand, Florida and Vietnam; settings and payment systems differ from U.S. health systems. |
| Disparities in testing and PrEP by age, gender, geography and coverage | [1] [6] [12] | 2026, 2025 | Equity and trust | Self-reported online survey in Australia and single-clinic U.S. data; not population-representative. |
| Workforce needs, clinician readiness and electronic partner notification | [9] [10] [14] | 2026, 2025 | Human infrastructure | Small qualitative and survey samples; Dublin clinician views may not generalize. |

About the author
Greg Wahlstrom
MBAHCM
President and Chief Executive Officer, The Healthcare Executive
View Greg’s profile©2014 – 2026 The Healthcare Executive. All rights reserved.

